Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ISMELIN

GUANETHIDINE MONOSULFATE

Standard Dose
EQ 10MG SULFATE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ISMELIN is listed in Drugs@FDA under application 012329 (NDA).

Marketing status: Discontinued Active ingredient GUANETHIDINE MONOSULFATE Form and strength TABLET;ORAL - EQ 10MG SULFATE Sponsor NOVARTIS Submission history Latest submission status date: 1986-10-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview ISMELIN is listed in Drugs@FDA under application 012329 (NDA). Marketing status: Discontinued Active ingredient GUANETHIDINE MONOSULFATE Form and strength TABLET;ORAL - EQ 10MG SULFATE Sponsor NOVARTIS Submission history Latest submission status date: 1986-10-22 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.